Plasmodium vivax malaria
MONDO:0005921Malaria resulting from infection by Plasmodium vivax.
Also known as: vivax malaria
30 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Can a short drug course end malaria relapses for good?
⭐️ CURE ⭐️ CompletedThis study tested how well the drug primaquine prevents the return of P. vivax malaria in 160 adults. Participants had uncomplicated malaria and normal G6PD levels. The goal was to see if a short treatment could stop relapses, aiming for a complete cure.
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
New short-course malaria cure could save thousands
⭐️ CURE ⭐️ CompletedThis study tested a new way to cure vivax malaria, a type of malaria that can come back. Researchers gave a high daily dose of the drug primaquine for a short time, but only after a quick test to check for a genetic condition (G6PD deficiency) that could cause serious side effect…
Phase: NA • Sponsor: Menzies School of Health Research • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 08:11 UTC
-
Can At-Home malaria pills work as well as supervised care?
Disease control CompletedThis trial compares two ways of taking the standard malaria treatment for Plasmodium vivax: one group receives chloroquine and primaquine under direct medical supervision, while the other takes the same medication at home with phone check-ins. The goal is to see if unsupervised t…
Phase: NA • Sponsor: Jimma University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New Short-Course malaria treatment could prevent relapses
Disease control CompletedThis study tested a new approach to treat vivax malaria, a type that can hide in the liver and come back. Researchers used a quick test to check for a genetic condition (G6PD deficiency) that can cause dangerous side effects with the standard drug primaquine. Then, they gave a hi…
Phase: NA • Sponsor: Macfarlane Burnet Institute for Medical Research and Public Health Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Malaria-Fighting drug given to entire villages shows promise
Disease control CompletedThis study tested giving a single dose of the drug tafenoquine to everyone in three villages in Myanmar to see if it could safely stop the spread of P. vivax malaria. Over 1,200 people took part, and researchers tracked side effects and malaria cases for six months. The goal was …
Phase: PHASE4 • Sponsor: Shoklo Malaria Research Unit • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could targeted drug dosing stamp out malaria in thai hotspots?
Prevention CompletedThis study tested whether giving antimalarial drugs to everyone in high-risk villages and forest workers could lower malaria cases in Thailand. Over 14,000 people took part. The goal was to see if this approach reduces infections from both Plasmodium falciparum and Plasmodium viv…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
Scientists deliberately infect volunteers with malaria to study the disease
Knowledge-focused CompletedThis study aims to see if it's safe and possible to give healthy Thai adults a controlled infection of P. vivax malaria through mosquito bites. Six volunteers will be infected and monitored closely. The goal is to develop a reliable model for future research on malaria and immune…
Phase: NA • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New malaria treatment plan put to the test in peru
Knowledge-focused CompletedThis study looked at whether a new way to treat Malaria Vivax is practical for healthcare workers in Peru. The plan includes a simple test to check a patient's G6PD enzyme level before giving one of two medicines, tafenoquine or primaquine. Researchers trained healthcare provider…
Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC